查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1811009

2025年精准基因组检测全球市场报告

Precision Genomic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

精准基因组检测市场预计在未来几年内将快速成长，到2029年将达到231.1亿美元，复合年增长率为11.4%。预测期内的成长可归因于对精准肿瘤学解决方案的需求不断增长、对罕见疾病诊断的日益关注、对群体基因组学倡议的投资不断增加、多体学方法的应用不断扩大以及对无创产前检测的需求不断增长。预计在此期间的主要趋势包括：次世代定序仪技术的进步、液态切片技术的创新、人工智慧在基因组分析中的整合、对多体学数据解读的改进以及不断发展的直接面向消费者的基因检测模式。

预计遗传疾病盛行率的不断上升将在未来几年推动精准基因组检测市场的成长。遗传疾病是由个体 DNA 异常引起的疾病，可能涉及单基因突变、多基因突变或染色体的结构或数值变化。遗传疾病的增加主要是由于母亲年龄的增长，因为高龄母亲生下患有唐氏症等染色体异常儿童的风险更高。精准基因组检测透过识别特定的基因突变，支持有针对性的干预和个人化治疗计划，能够早期发现和准确诊断遗传疾病。例如，2025 年 5 月，英国註册慈善机构 Gene People 报告称，英国每 25 名儿童中就有 1 名患有遗传疾病，影响人数超过 240 万人。此外，英国每年约有 30,000 名新生儿和儿童被诊断出患有遗传疾病。因此，遗传疾病的盛行率不断上升，刺激了精准基因组检测市场的成长。

精准基因组检测市场中的公司正专注于开发尖端技术，例如超灵敏的循环肿瘤 DNA 检测，以提高早期癌症检测和诊断的准确性。这些检测能够识别血液中存在的肿瘤 DNA 微小片段，从而更早、更准确地检测出与癌症相关的基因突变。例如，2025 年 4 月，美国临床基因检测公司 Natera Inc. 推出了超灵敏的 Signatera 基因组分子残留疾病检测。此检测应用患者肿瘤 DNA 和匹配的正常 DNA 的全基因组定序来创建个人化检测，从而能够检测到低至百万分之一的极低浓度的循环肿瘤 DNA。如此高的灵敏度使得早期发现癌症復发成为可能，从而改善多种癌症类型的治疗计划和患者照护。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球精准基因组检测：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球精准基因组检测市场：成长率分析
  • 全球精准基因组检测市场表现：规模与成长，2019-2024
  • 全球精准基因组检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球精准基因组检测：总潜在市场（TAM）

第六章市场区隔

  • 全球精准基因组检测市场（依产品及服务、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 装置
  • 服务
  • 全球精准基因组检测市场：依技术、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序
  • 聚合酵素链锁反应
  • 微阵列技术
  • 桑格定序
  • 丛集的规律间隔的短回文重复序列或丛集的规律间隔的短回文重复序列相关系统
  • 其他技术
  • 全球精准基因组检测市场：应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 肿瘤学
  • 心血管疾病
  • 神经系统疾病
  • 生殖健康
  • 罕见疾病
  • 其他用途
  • 全球精准基因组检测市场：按最终用户、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他最终用户
  • 全球精准基因组检测市场：按耗材细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 试剂和套件
  • 去氧核糖核酸或核糖核酸萃取套件
  • 文库製备试剂套件
  • 定序试剂
  • 聚合酵素链锁反应检测试剂套件
  • 缓衝液和酶
  • 全球精准基因组检测市场：按设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序系统
  • 聚合酵素链锁反应装置
  • 微阵列设备
  • 去氧核糖核酸分析仪
  • 生物资讯工作站
  • 实验室自动化系统
  • 全球精准基因组检测市场：依服务类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 基因组数据分析服务
  • 实验室测试服务
  • 遗传咨询服务
  • 临床解释服务
  • 合约研究服务
  • 客製化检测开发服务

第七章 区域和国家分析

  • 全球精准基因组检测市场：按地区、结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球精准基因组检测市场：依国家、地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 精准基因组检测市场：竞争格局
  • 精准基因组检测市场：公司简介
    • Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Revvity Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • GenScript Biotech Corporation
  • Fulgent Genetics Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • Ambry Genetics Corporation
  • Color Health Inc.
  • Pacific Biosciences
  • Eurofins Genomics LLC
  • Precision Genetics

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年精准基因组检测市场：哪些国家将带来新机会
  • 2029年精准基因组检测市场：细分领域带来新机会
  • 2029年精准基因组检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r37112

Precision genomic testing involves the use of advanced genetic analysis to detect specific DNA variations or mutations that impact an individual's risk of disease, diagnosis, prognosis, or treatment response. This approach supports personalized healthcare by enabling tailored prevention strategies, therapeutic interventions, and drug selection based on a person's unique genetic profile.

The key products and services in precision genomic testing include consumables, equipment, and services. Consumables are items intended for single or repeated use and are depleted through routine procedures, examples include laboratory reagents and medical supplies. The testing employs a variety of advanced technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, Sanger sequencing, and CRISPR-associated systems. It is applied across multiple areas, including oncology, cardiovascular diseases, neurological disorders, reproductive health, rare diseases, and more. End users include hospitals and clinics, diagnostic laboratories, research and academic institutions, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The precision genomic testing market research report is one of a series of new reports from The Business Research Company that provides precision genomic testing market statistics, including precision genomic testing global market size, regional shares, competitors with precision genomic testing market share, detailed precision genomic testing market segments, market trends and opportunities, and any further data you may need to thrive in the precision genomic testing industry. The precision genomic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision genomic testing market size has grown rapidly in recent years. It will grow from $13.44 billion in 2024 to $15.00 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. Growth in the historic period can be attributed to the increasing availability of direct-to-consumer genetic testing, rising collaborations between pharmaceutical and diagnostic companies, a heightened focus on preventive healthcare, greater adoption of companion diagnostics, and growing awareness of the importance of early disease detection.

The precision genomic testing market size is expected to see rapid growth in the next few years. It will grow to $23.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. Growth in the forecast period can be attributed to the rising demand for precision oncology solutions, increased focus on rare disease diagnostics, growing investment in population genomics initiatives, expanded use of multi-omics approaches, and the rising demand for non-invasive prenatal testing. Key trends expected during this period include advancements in next-generation sequencing technologies, innovations in liquid biopsy techniques, integration of artificial intelligence in genomic analysis, improvements in multi-omics data interpretation, and the evolution of direct-to-consumer genetic testing models.

The increasing prevalence of genetic disorders is anticipated to drive the growth of the precision genomic testing market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's DNA, which may involve mutations in a single gene, multiple genes, or structural or numerical changes in chromosomes. This rise in genetic disorders is largely attributed to the increasing maternal age, as older mothers face a higher risk of having children with chromosomal abnormalities, such as Down syndrome. Precision genomic testing allows for early detection and accurate diagnosis of genetic disorders by identifying specific genetic mutations, which supports targeted interventions and personalized treatment plans. For example, in May 2025, Gene People, a UK-based registered charity, reported that genetic conditions affect approximately 1 in 25 children, impacting over 2.4 million individuals in the UK. Additionally, around 30,000 newborns and children are diagnosed with a genetic condition each year in the UK. As a result, the rising incidence of genetic disorders is fueling the growth of the precision genomic testing market.

Companies in the precision genomic testing market are focusing on the development of advanced technologies, such as ultra-sensitive circulating tumor DNA assays, to improve early cancer detection and diagnostic accuracy. These assays are capable of identifying minute fragments of tumor-derived DNA present in the bloodstream, which enables earlier and more precise detection of genetic mutations associated with cancer. For instance, in April 2025, Natera Inc., a US-based clinical genetic testing company, launched the ultra-sensitive Signatera genome molecular residual disease test. This test applies whole genome sequencing of both the patient's tumor and matched normal DNA to create a personalized assay, enabling detection of circulating tumor DNA at extremely low concentrations-down to 1 part per million. Such high sensitivity allows for earlier detection of cancer recurrence, improving treatment planning and patient care across multiple cancer types.

In November 2022, Myriad Genetics Inc., a US-based healthcare company, acquired Gateway Genomics LLC for $67.5 million. This acquisition was aimed at strengthening Myriad Genetics' women's health portfolio by expanding into the early prenatal testing segment. The addition of Gateway Genomics' SneakPeek early gender DNA test broadens Myriad's offerings in the consumer genetic testing space. Gateway Genomics LLC, based in the US, specializes in the development of genetic-based tests for consumers, particularly focused on early prenatal applications.

Major players in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, and Precision Genetics.

North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in precision genomic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the precision genomic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision genomic testing market consists of revenues earned by entities by providing services such as gene panel testing, whole genome and exome analysis, pharmacogenomics testing, cancer genomics profiling, hereditary disease screening, and bioinformatics-driven interpretation of genetic data. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision genomic testing market also includes sales of hybridization buffers and enzymes, targeted gene panels, library preparation kits, genomic data compression tools, and rare mutation detection kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Genomic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision genomic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision genomic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision genomic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Consumables; Equipment; Services
  • 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray Technology; Sanger Sequencing; Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems; Other Technologies
  • 3) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Reproductive Health; Rare Diseases; Other Applications
  • 4) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutes; Other End-Users
  • Subsegments:
  • 1) By Consumables: Reagents And Kits; Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits; Library Preparation Kits; Sequencing Reagents; Polymerase Chain Reaction Assay Kits; Buffers And Enzymes
  • 2) By Equipment: Next-Generation Sequencing Systems; Polymerase Chain Reaction Machines; Microarray Instruments; Deoxyribonucleic Acid Analyzers; Bioinformatics Workstations; Laboratory Automation Systems
  • 3) By Services: Genomic Data Analysis Services; Laboratory Testing Services; Genetic Counseling Services; Clinical Interpretation Services; Contract Research Services; Custom Assay Development Services
  • Companies Mentioned: Roche Diagnostics International AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; QIAGEN N.V.; Exact Sciences Corporation; Natera Inc.; Myriad Genetics Inc.; GenScript Biotech Corporation; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Ambry Genetics Corporation; Color Health Inc.; Pacific Biosciences; Eurofins Genomics LLC; Precision Genetics.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Genomic Testing Market Characteristics

3. Precision Genomic Testing Market Trends And Strategies

4. Precision Genomic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Precision Genomic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Precision Genomic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Precision Genomic Testing Market Growth Rate Analysis
  • 5.4. Global Precision Genomic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Precision Genomic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Precision Genomic Testing Total Addressable Market (TAM)

6. Precision Genomic Testing Market Segmentation

  • 6.1. Global Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Equipment
  • Services
  • 6.2. Global Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray Technology
  • Sanger Sequencing
  • Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems
  • Other Technologies
  • 6.3. Global Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Reproductive Health
  • Rare Diseases
  • Other Applications
  • 6.4. Global Precision Genomic Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research And Academic Institutes
  • Other End-Users
  • 6.5. Global Precision Genomic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits
  • Library Preparation Kits
  • Sequencing Reagents
  • Polymerase Chain Reaction Assay Kits
  • Buffers And Enzymes
  • 6.6. Global Precision Genomic Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing Systems
  • Polymerase Chain Reaction Machines
  • Microarray Instruments
  • Deoxyribonucleic Acid Analyzers
  • Bioinformatics Workstations
  • Laboratory Automation Systems
  • 6.7. Global Precision Genomic Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomic Data Analysis Services
  • Laboratory Testing Services
  • Genetic Counseling Services
  • Clinical Interpretation Services
  • Contract Research Services
  • Custom Assay Development Services

7. Precision Genomic Testing Market Regional And Country Analysis

  • 7.1. Global Precision Genomic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Precision Genomic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Precision Genomic Testing Market

  • 8.1. Asia-Pacific Precision Genomic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Precision Genomic Testing Market

  • 9.1. China Precision Genomic Testing Market Overview
  • 9.2. China Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Precision Genomic Testing Market

  • 10.1. India Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Precision Genomic Testing Market

  • 11.1. Japan Precision Genomic Testing Market Overview
  • 11.2. Japan Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Precision Genomic Testing Market

  • 12.1. Australia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Precision Genomic Testing Market

  • 13.1. Indonesia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Precision Genomic Testing Market

  • 14.1. South Korea Precision Genomic Testing Market Overview
  • 14.2. South Korea Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Precision Genomic Testing Market

  • 15.1. Western Europe Precision Genomic Testing Market Overview
  • 15.2. Western Europe Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Precision Genomic Testing Market

  • 16.1. UK Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Precision Genomic Testing Market

  • 17.1. Germany Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Precision Genomic Testing Market

  • 18.1. France Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Precision Genomic Testing Market

  • 19.1. Italy Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Precision Genomic Testing Market

  • 20.1. Spain Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Precision Genomic Testing Market

  • 21.1. Eastern Europe Precision Genomic Testing Market Overview
  • 21.2. Eastern Europe Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Precision Genomic Testing Market

  • 22.1. Russia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Precision Genomic Testing Market

  • 23.1. North America Precision Genomic Testing Market Overview
  • 23.2. North America Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Precision Genomic Testing Market

  • 24.1. USA Precision Genomic Testing Market Overview
  • 24.2. USA Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Precision Genomic Testing Market

  • 25.1. Canada Precision Genomic Testing Market Overview
  • 25.2. Canada Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Precision Genomic Testing Market

  • 26.1. South America Precision Genomic Testing Market Overview
  • 26.2. South America Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Precision Genomic Testing Market

  • 27.1. Brazil Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Precision Genomic Testing Market

  • 28.1. Middle East Precision Genomic Testing Market Overview
  • 28.2. Middle East Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Precision Genomic Testing Market

  • 29.1. Africa Precision Genomic Testing Market Overview
  • 29.2. Africa Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Precision Genomic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Precision Genomic Testing Market Competitive Landscape
  • 30.2. Precision Genomic Testing Market Company Profiles
    • 30.2.1. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Precision Genomic Testing Market Other Major And Innovative Companies

  • 31.1. Revvity Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Natera Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. GenScript Biotech Corporation
  • 31.7. Fulgent Genetics Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Ambry Genetics Corporation
  • 31.12. Color Health Inc.
  • 31.13. Pacific Biosciences
  • 31.14. Eurofins Genomics LLC
  • 31.15. Precision Genetics

32. Global Precision Genomic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Genomic Testing Market

34. Recent Developments In The Precision Genomic Testing Market

35. Precision Genomic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Precision Genomic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Precision Genomic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Precision Genomic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer